References
1. Shi S, Qin M, Shen B, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.JAMA Cardiol. Published online March 25, 2020. doi:10.1001/jamacardio.2020.0950
Lippi G., Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020.
  1. Y. Zhang, M. Xiao, S. Zhang, P. Xia, W. Cao, W. Jiang, H. Chen, X. Ding, H. Zhao, H. Zhang, C. Wang, J. Zhao, X. Sun, R. Tian, W. Wu, D. Wu, J. Ma, Y. Chen, D. Zhang, J. Xie, X. Yan, X. Zhou, Z. Liu, J. Wang, B. Du, Y. Qin, P. Gao, X. Qin, Y. Xu, W. Zhang, T. Li, F. Zhang, Y. Zhao, Y. Li, S. Zhang, Coagulopathy and Antiphospholipid Antibodies in Patients with Covid -19, N. Engl. J. Med. (2020). https://doi.org/10.1056/NEJMc2007575
  2. F.A. Klok, et al., Thrombosis Research, https://doi.org/10.1016/j.thromres.2020.04.013
  3. Fox, Sharon & Akmatbekov, Aibek & Harbert, Jack & Li, Guang & Brown, J. & Heide, Richard. (2020). Pulmonary and Cardiac Pathology in Covid-19: The First Autopsy Series from New Orleans. 10.1101/2020.04.06.20050575.
  4. Tang, N., Bai, H., Chen, X., Gong, J., Li, D. and Sun, Z. (2020), Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. Accepted Author Manuscript. doi:10.1111/jth.14817